Centaur Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FLUPHENAZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 36326.
Remarkably, this DMF maintains an Active status since its submission on September 23, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 12, 2021, and payment made on September 27, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II